CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 106 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,000 | +150.0% | 2,660 | +622.8% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 368 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -91.4% | 368 | -85.9% | 0.00% | – |
| Q1 2019 | $35,000 | +483.3% | 2,601 | +281.9% | 0.00% | – |
| Q4 2018 | $6,000 | -70.0% | 681 | -63.9% | 0.00% | – |
| Q3 2018 | $20,000 | 0.0% | 1,888 | +23.8% | 0.00% | – |
| Q2 2018 | $20,000 | +17.6% | 1,525 | +17.3% | 0.00% | – |
| Q1 2018 | $17,000 | +466.7% | 1,300 | +333.3% | 0.00% | – |
| Q4 2017 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |